Cargando…
Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness, and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
A scorpion peptide reported to exhibit both analgesic and antitumor activity in animal models may present as an alternative therapeutic agent for breast cancer. We aimed to investigate the effect of Buthus martensii Karsch antitumor-analgesic peptide (BmK AGAP) on breast cancer cell stemness and epi...
Autores principales: | Kampo, Sylvanus, Ahmmed, Bulbul, Zhou, Tingting, Owusu, Lawrence, Anabah, Thomas Winsum, Doudou, Natacha Raissa, Kuugbee, Eugene Dogkotenge, Cui, Yong, Lu, Zhili, Yan, Qiu, Wen, Qing-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355678/ https://www.ncbi.nlm.nih.gov/pubmed/30740360 http://dx.doi.org/10.3389/fonc.2019.00021 |
Ejemplares similares
-
Corrigendum: Scorpion Venom Analgesic Peptide, BmK AGAP Inhibits Stemness and Epithelial-Mesenchymal Transition by Down-Regulating PTX3 in Breast Cancer
por: Kampo, Sylvanus, et al.
Publicado: (2021) -
Monitoring the Early Antiproliferative Effect of the Analgesic–Antitumor Peptide, BmK AGAP on Breast Cancer Using Intravoxel Incoherent Motion With a Reduced Distribution of Four b-Values
por: Doudou, Natacha Raissa, et al.
Publicado: (2019) -
Scorpion Venom peptide, AGAP inhibits TRPV1 and potentiates the analgesic effect of lidocaine
por: Kampo, Sylvanus, et al.
Publicado: (2021) -
Inhibition of spinal MAPKs by scorpion venom peptide BmK AGAP produces a sensory-specific analgesic effect
por: Ruan, Jia-Ping, et al.
Publicado: (2018) -
BmK-YA, an Enkephalin-Like Peptide in Scorpion Venom
por: Zhang, Yan, et al.
Publicado: (2012)